These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 34152015)

  • 21. Fluorofenidone inhibits UV-A induced senescence in human dermal fibroblasts via the mammalian target of rapamycin-dependent SIRT1 pathway.
    Lei D; Huang Y; Xie H; Yi Y; Long J; Lin S; Huang C; Jian D; Li J
    J Dermatol; 2018 Jul; 45(7):791-798. PubMed ID: 29726032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorofenidone inhibits apoptosis of renal tubular epithelial cells in rats with renal interstitial fibrosis.
    Yang H; Zhang W; Xie T; Wang X; Ning W
    Braz J Med Biol Res; 2019; 52(11):e8772. PubMed ID: 31664306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
    Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
    Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Protective Effect of Fluorofenidone against Cyclosporine A-Induced Nephrotoxicity.
    Chen Y; Wang N; Yuan Q; Qin J; Hu G; Li Q; Tao L; Xie Y; Peng Z
    Kidney Blood Press Res; 2019; 44(4):656-668. PubMed ID: 31387101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifibrotic effect of meloxicam in rat liver: role of nuclear factor kappa B, proinflammatory cytokines, and oxidative stress.
    Hassan MH; Ghobara MM
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Sep; 389(9):971-83. PubMed ID: 27245167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-renal fibrosis effect of asperulosidic acid via TGF-β1/smad2/smad3 and NF-κB signaling pathways in a rat model of unilateral ureteral obstruction.
    Xianyuan L; Wei Z; Yaqian D; Dan Z; Xueli T; Zhanglu D; Guanyi L; Lan T; Menghua L
    Phytomedicine; 2019 Feb; 53():274-285. PubMed ID: 30668407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBOA ameliorates CCl
    Sun X; Huang X; Zhu X; Liu L; Mo S; Wang H; Wei X; Lu S; Bai F; Wang D; Lin X; Lin J
    Biomed Pharmacother; 2019 Jul; 115():108901. PubMed ID: 31079002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifibrotic effects of Fraxetin on carbon tetrachloride-induced liver fibrosis by targeting NF-κB/IκBα, MAPKs and Bcl-2/Bax pathways.
    Wu B; Wang R; Li S; Wang Y; Song F; Gu Y; Yuan Y
    Pharmacol Rep; 2019 Jun; 71(3):409-416. PubMed ID: 31003150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and structure-activity relationship of 5-substituent-2(1H)-pyridone derivatives as anti-fibrosis agents.
    Chen J; Lu MM; Liu B; Chen Z; Li QB; Tao LJ; Hu GY
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2300-2. PubMed ID: 22342629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.
    Son G; Iimuro Y; Seki E; Hirano T; Kaneda Y; Fujimoto J
    Am J Physiol Gastrointest Liver Physiol; 2007 Sep; 293(3):G631-9. PubMed ID: 17640975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AICAR-Induced AMPK Activation Inhibits the Noncanonical NF-κB Pathway to Attenuate Liver Injury and Fibrosis in BDL Rats.
    Zhu H; Chai Y; Dong D; Zhang N; Liu W; Ma T; Wu R; Lv Y; Hu L
    Can J Gastroenterol Hepatol; 2018; 2018():6181432. PubMed ID: 30662889
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel salviadione derivative, compound 15a, attenuates diabetes-induced renal injury by inhibiting NF-κB-mediated inflammatory responses.
    Li L; Ding C; Zou C; Xiong Z; Zhu W; Qian J; Xu M; Zhang A; Liang G
    Toxicol Appl Pharmacol; 2020 Dec; 409():115322. PubMed ID: 33171189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models.
    Lixuan Z; Jingcheng D; Wenqin Y; Jianhua H; Baojun L; Xiaotao F
    Pulm Pharmacol Ther; 2010 Oct; 23(5):411-9. PubMed ID: 20566376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorofenidone Inhibits UUO/IRI-Induced Renal Fibrosis by Reducing Mitochondrial Damage.
    Liao X; Lv X; Zhang Y; Han Y; Li J; Zeng J; Tang D; Meng J; Yuan X; Peng Z; Tao L; Xie Y
    Oxid Med Cell Longev; 2022; 2022():2453617. PubMed ID: 35355864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatoprotective effect of fraxin against carbon tetrachloride-induced hepatotoxicity in vitro and in vivo through regulating hepatic antioxidant, inflammation response and the MAPK-NF-κB signaling pathway.
    Niu X; Liu F; Li W; Zhi W; Yao Q; Zhao J; Yang G; Wang X; Qin L; He Z
    Biomed Pharmacother; 2017 Nov; 95():1091-1102. PubMed ID: 28922728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
    Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
    J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorofenidone attenuates pulmonary inflammation and fibrosis via inhibiting the activation of NALP3 inflammasome and IL-1β/IL-1R1/MyD88/NF-κB pathway.
    Song C; He L; Zhang J; Ma H; Yuan X; Hu G; Tao L; Zhang J; Meng J
    J Cell Mol Med; 2016 Nov; 20(11):2064-2077. PubMed ID: 27306439
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Li L; Luo X; Cheng Z
    Xenobiotica; 2021 Jul; 51(7):745-751. PubMed ID: 32897767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gypsophila elegans isoorientin-2″-O-α-l-arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF-κB signaling pathway and suppressing HSC activation.
    Bai F; Huang Q; Wei J; Lv S; Chen Y; Liang C; Wei L; Lu Z; Lin X
    Int Immunopharmacol; 2018 Jan; 54():60-67. PubMed ID: 29107862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NR4A1 knockdown confers hepatoprotection against ischaemia-reperfusion injury by suppressing TGFβ1 via inhibition of CYR61/NF-κB in mouse hepatocytes.
    Cao J; Xu T; Zhou C; Wang S; Jiang B; Wu K; Ma L
    J Cell Mol Med; 2021 Jun; 25(11):5099-5112. PubMed ID: 33942481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.